Relationship between PC(36:4) and depression (count: 10) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M039 | Type1 | CRS group vs. control group | Plasma | Wistar rat | Down |
Study M081 | Type1 | CUMS group vs. control group | Liver | Wistar rat | Up |
Study M1110 | Type1 | CVS group vs. control group | Prefrontal cortex | C57BL/6 mouse | Down |
Study M1110 | Type1 | CVS group vs. control group | Hippocampus | C57BL/6 mouse | Down |
Study M123 | Type3 | rTMS group vs. control group | Striatum | Wistar rat | Up |
Study M123 | Type3 | rTMS group vs. control group | Prefrontal cortex | Wistar rat | Down |
Study M124 | Type3 | maprotiline group vs. control group | Prefrontal cortex | BALB/c mouse | Up |
Study M148 | Type1 | CUMS group vs. control group | Liver | Wistar rat | Up |
Study M148 | Type2 | CUMS + fluoxetine group vs. CUMS group | Liver | Wistar rat | Down |
Study M148 | Type2 | CUMS + CSGS group vs. CUMS group | Liver | Wistar rat | Up |
Study M690 | Type2 | CUMS + high dose of Zhi-zi-chi decoction group vs. CUMS group | Serum | Balb/c mouse | Up |
Study M789 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |
Study M789 | Type2 | CUMS + liquiritin group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |
Study M789 | Type2 | CUMS + fluoxetine group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |
Study M890 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |
Study M948 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |